Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Gastroenterology
»
Liver
»
Neoplasms
17. September 2026
Search
medline.ch
Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Biliary Tract
Liver
Hepatitis
Liver Cirrhosis
Neoplasms
Portal Hypertension
Others
Gastrointestinal
Esophagus
Pankreas
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 3875
Articles 1 - 20 / 77485
Design, Synthesis, In Vitro Biological Evaluation, and In Silico Studies of Novel Imidazo[4,5-b]Pyridine-Acrylonitrile-Based Derivatives as VEGFR-2 Inhibitors Against Breast Cancer and Hepatocellular Carcinoma.
Drug Dev Res
Mohamed LW, Saadeldin AA, Farag AB.
PMID: 42745397 [PubMed - indexed for MEDLINE]
Context-informed personalized segmentation from radiology reports: A fully automated framework for long-term liver tumor follow-up.
Med Phys
Chun J, Woodland M, Castelo A, O'Connor C, Altaie M, Gupta A, Ding S, Nguyen A, Koay EJ, Brock KK.
PMID: 42745158 [PubMed - indexed for MEDLINE]
Systemic therapy for HCC: Doublets, triplets and beyond.
J Hepatol
Vogel A, Kelley RK.
PMID: 42744526 [PubMed - indexed for MEDLINE]
Integrating systemic therapy in the earlier stages of liver cancer.
J Hepatol
Edeline J, Kuang M, Reig M, Vilgrain V.
PMID: 42744525 [PubMed - indexed for MEDLINE]
Liver transplantation for primary liver cancers in the era of transplant oncology.
J Hepatol
Mazzaferro V, Pinter M, Pillai A, Sposito C, Tabrizian P.
PMID: 42744523 [PubMed - indexed for MEDLINE]
Advances in the imaging of liver cancer.
J Hepatol
Joo I, Lee JM, Ronot M.
PMID: 42744522 [PubMed - indexed for MEDLINE]
ALPS-HCC Score: A Dynamic Liver Stiffness Measurement-Based Machine Learning Model to Predict Risk of Hepatocellular Carcinoma.
Liver Int
Huang Y, Yu H, Yang B, Jiang H, Hu C, Yu Q, Xi X, Li M, Lei Y, Wu B, Xie B, Ding H, Yang Y.
PMID: 42740543 [PubMed - indexed for MEDLINE]
Advances in Transarterial Radionuclide Therapy for Hepatocellular Carcinoma and Other Liver Tumors: From Yttrium-90 Radioembolization to Emerging Lipiodol-Based Theranostic Approaches.
Molecules
Kono Y, Utsunomiya K, Kariya S, Tanigawa N.
PMID: 42738690 [PubMed - indexed for MEDLINE]
Divergence of the CYB5R3-mARC1 Redox Axis Across the Human MASLD-to-Hepatocellular-Carcinoma Continuum: An Exploratory Analysis of Liver-Biopsy and Tumor Cohorts.
Int J Mol Sci
Nam SW.
PMID: 42737704 [PubMed - indexed for MEDLINE]
MicroRNA Control of Hepatocyte-Stromal Crosstalk in the Early Premalignant Microenvironment of HBV-Associated HCC.
Int J Mol Sci
Sartorius K, Kramvis A, Chuturgoon A.
PMID: 42737483 [PubMed - indexed for MEDLINE]
Microbiome-Immune Interactions as Determinants of Checkpoint Inhibitor Efficacy in Hepatocellular Carcinoma.
Int J Mol Sci
Ostafe MR, Volovat SR, Clement A, Litcanu CI, Tabarcea SI, Volovat CC, Panaite DI, Augustin IG, Volovat C.
PMID: 42737447 [PubMed - indexed for MEDLINE]
Comprehensive In Silico Analysis Identifies MSTO1 and LIG1 as Candidate Biomarkers With Diagnostic and Prognostic Relevance in Hepatocellular Carcinoma.
Cancer Rep (Hoboken)
Hamad J, Fayyad-Kazan H, Abdel-Sater F.
PMID: 42732946 [PubMed - indexed for MEDLINE]
The landscape of peripheral blood RNA modifications and its clinical implications for diagnosis of hepatocellular carcinoma.
Cell Commun Signal
Ge L, Shang M, He X, Cui F, Tao L, Dai S, Wang H, Hu B.
PMID: 42732057 [PubMed - indexed for MEDLINE]
FOLFOX-based transarterial infusion chemotherapy for unresectable colorectal cancer: protocol of an open-label, multicentre, randomised, controlled, phase II trial.
BMJ Open
Wang J, Sun Y, Chen L, Wang Z, Li K, Guo Y, Yao L, Duan L, Liu Q.
PMID: 42731846 [PubMed - indexed for MEDLINE]
Primary Hepatic Lymphoma with Hepatocellular Carcinoma: A Case Report.
J Vis Exp
Tang Y, Zhan Y, Xu X, Chen H, Wang J, Jiang Q, Pan Y, Xu J, Li T.
PMID: 42730702 [PubMed - indexed for MEDLINE]
Radiographic evidence of thymic involution in hepatocellular carcinoma: a propensity score-matched study in viral cirrhosis.
Front Immunol
Li J, Lakang Y, Zuo JX, Li H, Luo WL, Chen XM, Yang ZS, Xu HB, Zhou JY, Liang YB, Wang QB, Li YK, Wang W, Yang C, Guo L, Zhao XX, Ke Y.
PMID: 42729300 [PubMed - indexed for MEDLINE]
Late Ischemic Cholangiopathy After Liver Transplantation From a Deceased Donor With Situs Inversus Totalis: A Case Report.
Exp Clin Transplant
Meier RPH, Shirini K, Arcerito M, Hirsch J, Alvarez-Casas J, Bhati CS.
PMID: 42728710 [PubMed - indexed for MEDLINE]
Effect of Prior Hilar Manipulation During Previous Hepatectomy on Surgical Outcomes of Laparoscopic Repeat Hepatectomy.
Asian J Endosc Surg
Arai K, Gon H, Komatsu S, Fukushima K, Urade T, Yoshida T, Nanno Y, Yanagimoto H, Kido M, Fukumoto T.
PMID: 42727937 [PubMed - indexed for MEDLINE]
Percutaneous Cryoablation Versus Microwave Ablation for Hepatocellular Carcinoma: Comparative Study of Safety and Oncologic Outcomes.
Radiol Imaging Cancer
Chlorogiannis DD, Bhagavatula SK, Silverman SG, Dabiri BE, Tuncali K, Levesque VM, Gottumukkala RV, Lan Z, Shyn PB.
PMID: 42725882 [PubMed - indexed for MEDLINE]
Cost-effectiveness of tremelimumab plus durvalumab versus sorafenib for unresectable hepatocellular carcinoma in China: an economic evaluation based on five-year overall survival data from the HIMALAYA trial.
Front Public Health
Feng R, Liang P, Wang Y, Li D, Jia H, Zheng Y, Huo L, Lv Q.
PMID: 42723778 [PubMed - indexed for MEDLINE]
Articles 1 - 20 / 77485
Page 1 of 3875
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy